189 related articles for article (PubMed ID: 12857435)
1. Oxytocin and fetal membranes in preterm labor: current concepts and clinical implication.
Laudanski T; Pierzynski P
Gynecol Endocrinol; 2003 Jun; 17(3):261-7. PubMed ID: 12857435
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of premature labor in sheep by a combined treatment of nimesulide, a prostaglandin synthase type 2 inhibitor, and atosiban, an oxytocin receptor antagonist.
Grigsby PL; Poore KR; Hirst JJ; Jenkin G
Am J Obstet Gynecol; 2000 Sep; 183(3):649-57. PubMed ID: 10992188
[TBL] [Abstract][Full Text] [Related]
3. Review on prostaglandin and oxytocin activity in preterm labor.
Ivanisević M; Djelmis J; Buković D
Coll Antropol; 2001 Dec; 25(2):687-94. PubMed ID: 11811300
[TBL] [Abstract][Full Text] [Related]
4. [Tocolysis. Atosiban, an ocytcin-receptor antagonist].
Schmitz T; Cabrol D
J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):238-45. PubMed ID: 11397999
[TBL] [Abstract][Full Text] [Related]
5. Oxytocin receptor blockade: a new principle in the treatment of preterm labor?
Andersen LF; Lyndrup J; Akerlund M; Melin P
Am J Perinatol; 1989 Apr; 6(2):196-9. PubMed ID: 2540760
[TBL] [Abstract][Full Text] [Related]
6. Treatment of preterm labor with the oxytocin antagonist atosiban.
Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R
Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103
[TBL] [Abstract][Full Text] [Related]
7. Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban.
Bossmar T
J Perinat Med; 1998; 26(6):458-65. PubMed ID: 10224602
[TBL] [Abstract][Full Text] [Related]
8. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
Kim A; Shim JY
BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
[TBL] [Abstract][Full Text] [Related]
9. Oxytocin antagonists: clinical and scientific considerations.
Thornton S; Vatish M; Slater D
Exp Physiol; 2001 Mar; 86(2):297-302. PubMed ID: 11429647
[TBL] [Abstract][Full Text] [Related]
10. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin antagonists for the management of preterm birth: a review.
Usta IM; Khalil A; Nassar AH
Am J Perinatol; 2011 Jun; 28(6):449-60. PubMed ID: 21170825
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin and vasopressin V(1A) receptors as new therapeutic targets in assisted reproduction.
Pierzynski P
Reprod Biomed Online; 2011 Jan; 22(1):9-16. PubMed ID: 21130036
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin, its antagonist Atosiban, and preterm labor: a role for placental nitric oxide.
Nanetti L; Raffaelli F; Giulietti A; Sforza G; Raffaele Giannubilo S; Ciavattini A; Tranquilli AL; Mazzanti L; Vignini A
J Matern Fetal Neonatal Med; 2015 Mar; 28(5):611-6. PubMed ID: 24920283
[TBL] [Abstract][Full Text] [Related]
14. Profile of an oxytocin antagonist, RWJ 22164 for treatment of preterm labor in laboratory models of uterine contractility.
Demarest KT; Hahn DW; Ericson E; Capetola RJ; Fuchs AR; McGuire JL
Am J Perinatol; 1989 Apr; 6(2):200-4. PubMed ID: 2712917
[TBL] [Abstract][Full Text] [Related]
15. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
Valenzuela GJ; Sanchez-Ramos L; Romero R; Silver HM; Koltun WD; Millar L; Hobbins J; Rayburn W; Shangold G; Wang J; Smith J; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin receptor antagonists. Update.
Goodwin TM; Zograbyan A
Clin Perinatol; 1998 Dec; 25(4):859-71, vi. PubMed ID: 9891619
[TBL] [Abstract][Full Text] [Related]
17. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
Reinheimer TM
BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
[TBL] [Abstract][Full Text] [Related]
18. SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor.
Serradeil-Le Gal C; Valette G; Foulon L; Germain G; Advenier C; Naline E; Bardou M; Martinolle JP; Pouzet B; Raufaste D; Garcia C; Double-Cazanave E; Pauly M; Pascal M; Barbier A; Scatton B; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 2004 Apr; 309(1):414-24. PubMed ID: 14722330
[TBL] [Abstract][Full Text] [Related]
19. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban.
Bossmar T; Akerlund M; Fantoni G; Szamatowicz J; Melin P; Maggi M
Am J Obstet Gynecol; 1994 Dec; 171(6):1634-42. PubMed ID: 7802081
[TBL] [Abstract][Full Text] [Related]
20. Effect of an oxytocin receptor antagonist (atosiban) on uterine electrical activity.
Hadar E; Melamed N; Aviram A; Raban O; Saltzer L; Hiersch L; Yogev Y
Am J Obstet Gynecol; 2013 Oct; 209(4):384.e1-7. PubMed ID: 23727522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
